BPC-157

BPC-157 is a synthetic 15-amino-acid peptide fragment originally isolated from human gastric juice, where it occurs as part of a larger body-protective protein. Since its initial characterization, this compound has attracted considerable scientific attention due to its broad regenerative profile observed in preclinical models.

Research Highlights

1. Tissue Regeneration and Wound Repair

Laboratory investigations using rodent models have demonstrated that BPC-157 accelerates the repair of diverse tissue injuries, including tendon ruptures, muscle tears, ligament damage, and skin burns. The peptide appears to enhance fibroblast recruitment, stimulate collagen deposition, and promote re-epithelialization through activation of the ERK1/2 signaling cascade. Notably, studies on tendon fibroblasts revealed dose-dependent increases in growth hormone receptor expression, with up to sevenfold elevations observed by the third day of treatment.

2. Vascular Growth and Collateral Formation

BPC-157 has been identified as a potent angiogenic factor that promotes endothelial cell proliferation via VEGFR2 receptor stimulation within the nitric oxide signaling pathway. In vivo experiments showed the peptide rapidly restoring blood flow through collateral vessel activation in models of venous occlusion, an effect closely linked to the NO system and reduction of free radical formation.

3. Cytoprotective and Anti-Ulcer Activity

As a cytoprotective mediator, BPC-157 demonstrates protective effects on the gastrointestinal mucosal barrier while simultaneously addressing lesions in the liver, brain, and cardiovascular tissue.

4. Tendon and Connective Tissue Healing

Preclinical evidence indicates that BPC-157 stimulates F-actin production in fibroblasts and enhances phosphorylation of paxillin and FAK proteins — critical mediators of cell migration.

5. Antioxidant Properties

BPC-157 appears capable of neutralizing markers of oxidative stress, including nitric oxide and malondialdehyde.

6. Drug Side Effect Mitigation

Animal studies suggest BPC-157 may counteract adverse effects of certain pharmaceuticals, particularly NSAIDs, neuroleptics, and prokinetics.

References available upon request.

The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.